NO974696L - Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer - Google Patents

Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer

Info

Publication number
NO974696L
NO974696L NO974696A NO974696A NO974696L NO 974696 L NO974696 L NO 974696L NO 974696 A NO974696 A NO 974696A NO 974696 A NO974696 A NO 974696A NO 974696 L NO974696 L NO 974696L
Authority
NO
Norway
Prior art keywords
chlorophenylthiocarbamates
chlorophenylcarbamates
virus
inhibition
pharmaceutical preparation
Prior art date
Application number
NO974696A
Other languages
English (en)
Norwegian (no)
Other versions
NO974696D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/420,913 external-priority patent/US5629341A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO974696D0 publication Critical patent/NO974696D0/no
Publication of NO974696L publication Critical patent/NO974696L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974696A 1995-04-12 1997-10-10 Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer NO974696L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/420,913 US5629341A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of viruses and cancers
US188895P 1995-08-04 1995-08-04
PCT/US1996/004956 WO1996032104A1 (en) 1995-04-12 1996-04-11 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers

Publications (2)

Publication Number Publication Date
NO974696D0 NO974696D0 (no) 1997-10-10
NO974696L true NO974696L (no) 1997-12-12

Family

ID=26669618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974696A NO974696L (no) 1995-04-12 1997-10-10 Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer

Country Status (21)

Country Link
US (3) US5932604A (cs)
EP (1) EP0820281B1 (cs)
JP (1) JPH11503460A (cs)
KR (1) KR19980703829A (cs)
CN (1) CN1181701A (cs)
AT (1) ATE367808T1 (cs)
AU (1) AU714056B2 (cs)
BR (1) BR9604973A (cs)
CA (1) CA2217953C (cs)
CZ (1) CZ323597A3 (cs)
DE (1) DE69637178D1 (cs)
HU (1) HUP9900901A3 (cs)
IL (1) IL117874A0 (cs)
NO (1) NO974696L (cs)
NZ (1) NZ305785A (cs)
PL (1) PL322732A1 (cs)
RU (1) RU2170577C2 (cs)
SK (1) SK138397A3 (cs)
TR (2) TR199801216T2 (cs)
TW (1) TW422685B (cs)
WO (1) WO1996032104A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
CZ323597A3 (cs) 1995-04-12 1998-03-18 The Procter & Gamble Company Farmaceutický prostředek obsahující N-chlorfenylkarbamáty a N-chlorfenylthiocarbamaty pro inhibici růstu virů a karcinom
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
JP2002540149A (ja) * 1999-03-31 2002-11-26 ザ プロクター アンド ギャンブル カンパニー ウイルス感染治療のためのカルバミン酸エステル誘導体の使用法
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
RU2222326C1 (ru) * 2002-10-09 2004-01-27 Российский онкологический научный центр им. Н.Н.Блохина РАМН Способ лечения саркомы юинга
RU2268037C1 (ru) * 2004-04-22 2006-01-20 Германов Евгений Павлович Лекарственное средство
CN119751311A (zh) * 2025-01-07 2025-04-04 珠海市暨南大学珠海研究院 一种有机化合物或其药学上可接受的盐和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734911A (en) * 1956-02-14 Reaction of chloroaniline and isopropyl
US2695225A (en) * 1954-05-21 1954-11-23 Columbia Southern Chem Corp Herbicidal compositions
US2806051A (en) * 1955-11-01 1957-09-10 Goodrich Co B F Method for preparing urethanes by reacting urea, amines and an alcohol
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5629341A (en) * 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
CZ323597A3 (cs) * 1995-04-12 1998-03-18 The Procter & Gamble Company Farmaceutický prostředek obsahující N-chlorfenylkarbamáty a N-chlorfenylthiocarbamaty pro inhibici růstu virů a karcinom
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals

Also Published As

Publication number Publication date
BR9604973A (pt) 1998-06-09
CN1181701A (zh) 1998-05-13
CA2217953C (en) 2001-12-04
EP0820281A1 (en) 1998-01-28
TW422685B (en) 2001-02-21
DE69637178D1 (de) 2007-09-06
CA2217953A1 (en) 1996-10-17
NO974696D0 (no) 1997-10-10
TR199701151T1 (xx) 1998-03-21
NZ305785A (en) 2001-10-26
US6251870B1 (en) 2001-06-26
RU2170577C2 (ru) 2001-07-20
EP0820281B1 (en) 2007-07-25
IL117874A0 (en) 1996-08-04
WO1996032104A1 (en) 1996-10-17
KR19980703829A (ko) 1998-12-05
HUP9900901A2 (hu) 1999-08-30
TR199801216T2 (xx) 1998-09-21
AU5389896A (en) 1996-10-30
ATE367808T1 (de) 2007-08-15
CZ323597A3 (cs) 1998-03-18
US5932609A (en) 1999-08-03
US5932604A (en) 1999-08-03
SK138397A3 (en) 1998-05-06
PL322732A1 (en) 1998-02-16
JPH11503460A (ja) 1999-03-26
AU714056B2 (en) 1999-12-16
HUP9900901A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
NO974696L (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
NO20016304L (no) Erytropoetinkonjugater med polyetylenglykol, fremstilling av slike konjugater, preparater omfattende slike konjugater samt anvendelse av slike konjugater for fremstilling av medikamenter for forebygging eller behandling av sykdom
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
MX9102110A (es) Muteina de factor de necrosis tumoral humano o una sal farmaceuticamente aceptable de la misma,procedimiento para su preparacion y composicion farmaceutica que la contiene
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
MY107843A (en) Anti-viral compounds.
MX14663A (es) Procedimiento para la preparacion de derivados de quinazolina, producto obtenido y composicion fungicida y acaricida que lo incluye.
CA2111580A1 (fr) Composes immunogenes a effet notamment anti-cytokine, procede de preparation, compositions pharmaceutiques et kits les renfermant
NO991701L (no) HIV og cancer behandling
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
FR2659234B1 (fr) Composition therapeutique contenant un compose phenol et de la propolis utile contre les virus a capside lipidique, notamment les virus de l'herpes.
AR002987A1 (es) Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
NO980419L (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
ES2185323T3 (es) Utilizacion de eritropoietina en el tratamiento del mieloma multiple.
FI832884A7 (fi) Desoksiuridiini-johdannaiset, niiden valmistusmenetelmät ja käyttö farmaseuttisina aineina.
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
ATE236651T1 (de) Materialen und verfahren im zusammenhang mit der inhibierung der wechselwirkung der p53 und mdm2
ES2071995T3 (es) Composicion para la activacion de macrofagia.
FI961380A0 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
NO965483L (no) Dinukleosid-5',5'-pyrofosfater
HUP9700661A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása rák megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application